See also Fluoroquinolones

General information

Grepafloxacin is a synthetic fluoroquinolone antibiotic with extensive tissue distribution and strong antibacterial activity in vivo [ , ]. However, it was withdrawn in 1999 because of its adverse cardiovascular effects, which included dysrhythmias [ ].

Drug studies

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here